Tuesday, Mar 1, 2022 | 1:00 PM ET
Digital Health Dealmaking by Biopharma and Tech: An Innovation Match Made in Heaven?
Digital health innovation is guaranteed to play a critical part in the future of biopharma. Innovative technology that can optimize drug discovery, facilitate clinical trials, harness real-world data, improve patient engagement, aid clinical decision-making and enhance personalized care is evolving at breakneck speed. Join our elite industry panel as they explore the most promising partnership strategies between biopharma and tech, rising opportunities and key challenges associated with digital health innovation deals, and how tech and other innovators can position themselves to become a part of biopharma’s digital shift.
Key topics will include:
· Highlights from the headlines in biopharma-tech partnerships
· Key considerations for successful collaborations
· Potential pitfalls and lessons learned in digital health innovation
· Trends, emerging opportunities and areas of anticipated developments
Kellie CombsPartner, FDA Regulatory & Digital Health Co-Chair, Ropes & Gray LLP
Megan BacaPartner, Digital Health Co-Lead, Ropes & Gray LLP
Chris KirbyGeneral Counsel, PathAI
Deb PfennigVP of Business Development, Diagnostics and Enabling Technologies, Janssen